Home » Topics » BioWorld Science

BioWorld Science
RSS

XNW-1011 demonstrates improved in vivo efficacy compared to ibrutinib

April 17, 2018

Presentations describe discovery, structure, mechanism and activity of AZD-4573

April 17, 2018

Phase I results for CPI-613 in combination with high-dose cytarabine and mitoxantrone in AML

April 17, 2018

Kalytera terminates preclinical programs for synthetic endocannabinoid compounds in bone disease

April 17, 2018

Stem-cell based regenerative treatment for Alzheimer's administered to first patients in Japan

April 16, 2018

New P2Y6 receptor agonists presented by Tufts University

April 16, 2018

Tiziana in license agreement with BWH for neurodegenerative diseases

April 16, 2018

Shire agrees to sell oncology business to Servier

April 16, 2018

Chugai Pharmaceutical presents new GLP-1 receptor agonists

April 16, 2018

Gilead divulges new PI3K inhibitors

April 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...